Global /Canada /Financial Services /Financial Conglomerates /WOLF
chevron_leftBack
Grey Wolf Animal Health Corp. logo

Grey Wolf Animal Health Corp.

WOLF
TSXV: WOLF Delayed
1.65CAD 0%
1.19 USD
As of 6 June 2026, Grey Wolf Animal Health Corp. has a market cap of $40.44M USD, ranking #32104 globally and #1025 in Canada. It ranks #3437 in the Financial Services sector, and #539 in the Financial Conglomerates industry.
Global Rank
32104
Country Rank
1025
Sector Rank
3437
Industry Rank
539
Key Stats
Market Cap
$40.44MUSD
56.42M CAD
Enterprise Value
$53.4MUSD
74.23M CAD
Revenue (TTM)
$25.64MUSD
35.76M CAD
EBITDA (TTM)
$4.85MUSD
6.73M CAD
Net Income (TTM)
$1.19MUSD
1.66M CAD
EBITDA Margin
19%
Profit Margin
4.6%
PE Ratio
34.1
PS Ratio
1.6
PB Ratio
1.8
EV/EBITDA
10.7
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Angela Cechetto open_in_new
Employees
40
Website
greywolfah.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 11% 14% 27% 31% 83%

News

Loading...

Markets

Exchange Ticker Price
TSX Venture Exchange
MIC: XTSX
PRIMARY
WOLF
Grey Wolf Animal Health Corp
ISIN: CA3978851044
Shares Out.:
34.192M1 Shares Float: 26.042M2
TV:
SA:
YF:
GF:
BA:
MS:
1.65 CAD
Cboe Canada
MIC: NEOE
WOLF
Grey Wolf Animal Health Corp
ISIN: CA3978851044
TV:
SA:
YF:
GF:
BA:
MS:
1.65 CAD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Grey Wolf Animal Health Corp.

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, cohesive bandages, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves. It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products. The company is headquartered in Toronto, Canada.

Similar Companies

Industry: Financial Conglomerates (Canada)
Name
Market Cap diff.
PE
$781.87M
2K%
708.4
$642.45M
896.19M CAD
1K%
6.0
$608.24M
848.46M CAD
1K%
-
$321.61M
695%
-
$321.34M
695%
40.6
$293.48M
626%
5.3
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$121.36B
1.14T SEK
300K%
5.9
402340
$71.41B
109.46T KRW
176K%
12.5
ITSA3
$30.39B
157.1B BRL
75K%
9.5
$22.19B
207.94B SEK
55K%
5.2
$19.01B
598.03B TWD
47K%
12.6
HAL
$17.88B
15.4B EUR
44K%
9.6
chevron_leftBack